ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,049.24
0.88%
US Tech 100
21,176.00
0.88%
다우존스 지수
44,025.81
0.00%
Bitcoin
104,997.17
-1.11%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC

  6. Daiichi Sankyo Co Ltd (PK) (DSKYF) 시세

Daiichi Sankyo Co Ltd (PK)

Daiichi Sankyo Co Ltd (PK) (DSKYF)

USOTC
28.655
0.00
(0.00%)
마감 22 1월 6:00AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
28.655
매수가
27.90
매도가
30.35
거래량
1,800
0.00 일간 변동폭 0.00
24.56 52주 범위 44.64
market_cap
54.926B
전일 종가
28.655
개장가
-
최근 거래 시간
1800
@
28.6649
(average)
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
54,220
발행 주식
1,916,787,029
배당수익률
16,329.87%
주가수익률
0.27
주당순이익(EPS)
104.72
매출
1.63T
순이익
200.73B

Daiichi Sankyo Co Ltd (PK) 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Biolog/vaccines
웹사이트
www.daiichisankyo.co.jp
본부
Chuo, Tokyo, Jpn
설립됨
2005
Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTC 시장 with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$28.66. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 24.56 to US$ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares in issue. The market capitalisation of Daiichi Sankyo (PK) is US$54.93 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.27.

DSKYF 최신 뉴스

추가 뉴스

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

15 4월 2015
PR Newswire (US)

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

01 4월 2015
PR Newswire (US)

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

28 6월 2011
PR Newswire (US)

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

04 4월 2011
PR Newswire (US)

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

02 12월 2010
PR Newswire (US)

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

01 12월 2010
PR Newswire (US)

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

12 10월 2010
PR Newswire (US)

Patients with Hypertension at Risk Due to Physician Inertia

Patients with Hypertension at Risk Due to Physician Inertia - New Supporting Hypertension Awareness and Research Europe-wide (SHARE) Survey Reports Findings at the 20th Annual Society of the...

21 6월 2010
PR Newswire (US)

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban

Daiichi Sankyo Submits First New Drug Application for Oral Factor Xa Inhibitor, Edoxaban - Innovative Once-Daily Oral Factor Xa Inhibitor Submitted for Approval in Japan PR Newswire TOKYO, April...

06 4월 2010
PR Newswire (US)

Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs

Bolsters Company's Expertise in Areas of Oncology and Hematology PARSIPPANY, N.J., Feb. 11 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. (DSI) announced today that Jay M. Feingold, M.D., Ph.D...

11 2월 2010
PR Newswire (US)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
12.6051026.0530.224.5654170727.01660574CS
4-0.945-3.1925675675729.630.224.5614952226.98464896CS
12-2.505-8.0391527599531.1634.7524.565422027.2258675CS
26-10.085-26.032524522538.7444.6424.562521027.78419181CS
52-2.025-6.6003911342930.6844.6424.562086029.31159856CS
1565.71524.912816041822.9444.6419.451166929.29861034CS
260-37.965-56.987391173866.6295.9617.61858829.1742701CS

DSKYF - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is US$ 28.655
How many Daiichi Sankyo (PK) shares are in issue?
Daiichi Sankyo (PK) has 1,916,787,029 shares in issue
What is the market cap of Daiichi Sankyo (PK)?
The market capitalisation of Daiichi Sankyo (PK) is USD 54.93B
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of US$ 24.56 to US$ 44.64 during the past year
What is the PE ratio of Daiichi Sankyo (PK)?
The price to earnings ratio of Daiichi Sankyo (PK) is 0.27
What is the cash to sales ratio of Daiichi Sankyo (PK)?
The cash to sales ratio of Daiichi Sankyo (PK) is 0.03
What is the reporting currency for Daiichi Sankyo (PK)?
Daiichi Sankyo (PK) reports financial results in JPY
What is the latest annual turnover for Daiichi Sankyo (PK)?
The latest annual turnover of Daiichi Sankyo (PK) is JPY 1.63T
What is the latest annual profit for Daiichi Sankyo (PK)?
The latest annual profit of Daiichi Sankyo (PK) is JPY 200.73B
What is the registered address of Daiichi Sankyo (PK)?
The registered address for Daiichi Sankyo (PK) is 3-5-1 NIHONBASHI-HONCHO, CHUO-KU, CHUO, TOKYO, 103-8426
What is the Daiichi Sankyo (PK) website address?
The website address for Daiichi Sankyo (PK) is www.daiichisankyo.co.jp
Which industry sector does Daiichi Sankyo (PK) operate in?
Daiichi Sankyo (PK) operates in the PHARMACEUTICAL BIOLOG/VACCINES sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0305
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0305
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0
AABVFAberdeen International Inc (PK)
US$ 0.0242
(0.00%)
0
AABKFAareal Bank AG (PK)
US$ 0.00
(0.00%)
0
AABBAsia Broadband Inc (PK)
US$ 0.0305
(0.00%)
0
AAALYAareal Bank AG (PK)
US$ 34.65
(0.00%)
0
AAAIFAlternative Investment Trust (PK)
US$ 0.55
(0.00%)
0

DSKYF Discussion

게시물 보기
Termite7 Termite7 7 년 전
Dead boards are FUN!!!!!!!!!!!!!!!!!!!!
👍️0
KwikKash KwikKash 10 년 전
👍️0
Soapy Bubbles Soapy Bubbles 14 년 전
Share Structure, Holders, and Other Information
http://www.daiichisankyo.com/ir/stockinfo/index.html
👍️0
Soapy Bubbles Soapy Bubbles 14 년 전
http://www.daiichisankyo.com/ir/index.html
👍️0

최근 히스토리

USOTC
DSKYF
Daiichi Sankyo (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유